Common cholesterol drug safe, may improve learning disabilities in patients with neurofibromatosis, study finds

Tuesday, September 27, 2011 - 18:30 in Health & Medicine

Researchers have found that a cholesterol-lowering statin drug appears to be safe in children with neurofibromatosis type 1 (NF1) and may improve learning disabilities, including verbal and nonverbal memory.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net